FROM:
European J Pain 2017 (Feb); 21 (2): 201–216 ~ FULL TEXT
J.J. Wong, P. Côté, D.A. Sutton, K. Randhawa, H. Yu, S. Varatharajan, R. Goldgrub,
M. Nordin, D.P. Gross, H.M. Shearer, L.J. Carroll, P.J. Stern, A. Ameis,
D. Southerst, S. Mior, M. Stupar, T. Varatharajan, A. Taylor-Vaisey
UOIT-CMCC Centre for the Study of Disability Prevention and Rehabilitation,
University of Ontario Institute of Technology (UOIT) and
Canadian Memorial Chiropractic College (CMCC),
Oshawa, ON, Canada.
jessica.wong@uoit.ca
BACKGROUND:   Low back pain (LBP) is a major health problem, having a substantial effect on peoples' quality of life and placing a significant economic burden on healthcare systems and, more broadly, societies. Many interventions to alleviate LBP are available but their cost effectiveness is unclear.
We conducted a systematic review of guidelines on the management of low back pain (LBP) to assess their methodological quality and guide care. We synthesized guidelines on the management of LBP published from 2005 to 2014 following best evidence synthesis principles. We searched MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane, DARE, National Health Services Economic Evaluation Database, Health Technology Assessment Database, Index to Chiropractic Literature and grey literature. Independent reviewers critically appraised eligible guidelines using AGREE II criteria. We screened 2504 citations; 13 guidelines were eligible for critical appraisal, and 10 had a low risk of bias.
According to high-quality guidelines:
(1) all patients with acute or chronic LBP should receive education, reassurance and instruction on self-management options;
(2) patients with acute LBP should be encouraged to return to activity and may benefit from paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs), or spinal manipulation;
(3) the management of chronic LBP may include exercise, paracetamol or NSAIDs, manual therapy, acupuncture, and multimodal rehabilitation (combined physical and psychological treatment); and
(4) patients with lumbar disc herniation with radiculopathy may benefit from spinal manipulation.
Ten guidelines were of high methodological quality, but updating and some methodological improvements are needed. Overall, most guidelines target nonspecific LBP and recommend education, staying active/exercise, manual therapy, and paracetamol or NSAIDs as first-line treatments. The recommendation to use paracetamol for acute LBP is challenged by recent evidence and needs to be revisited.
SIGNIFICANCE:   Most high-quality guidelines recommend education, staying active/exercise, manual therapy and paracetamol/NSAIDs as first-line treatments for LBP. Recommendation of paracetamol for acute LBP is challenged by recent evidence and needs updating.
From the FULL TEXT Article:
Introduction
More than 80% of people experience at least one episode
of back pain during their lifetime (Cassidy et al.,
1998; Walker, 2000). Back pain is a common source
of disability, whether the pain is attributed to work,
traffic collisions, activities of daily living, or insidious
onset (Cassidy et al., 1998, 2005; Hincapie et al.,
2010). Back pain is costly, accounting for a considerable
proportion of work absenteeism and lost productivity
(Carey et al., 1995, 1996). Moreover, it is the
most common reason for visiting a healthcare provider
for musculoskeletal complaints (Cypress, 1983;
Cote et al., 2001). Although multiple clinical interventions
are available to treat back pain, current
evidence suggests that their effects appear small and
short term (Haldeman and Dagenais, 2008).
Clinical practice guidelines are systematically developed
statements that include recommendations
intended to optimize patient care and improve
patients’ health outcomes (Shekelle et al., 1999, 2012;
Institute of Medicine Committee on Standards for
Developing Trustworthy Clinical Practice Guidelines,
2011). Guidelines aim to reduce the gap between
research and clinical practice and assist policy makers
with decisions that impact the population (Whitworth,
2006; Alonso-Coello et al., 2010). However, concerns
have been raised about the quality of many clinical
practice guidelines (Ransohoff et al., 2013). Systematic
reviews report that some guidelines have methodological
limitations (Shaneyfelt et al., 1999; Graham et al.,
2001; Hasenfeld and Shekelle, 2003; Alonso-Coello
et al., 2010; Berrigan et al., 2011; Knai et al., 2012).
Common flaws include poor literature review
methodology, limited involvement of stakeholders
and unclear editorial independence (Alonso-Coello
et al., 2010). Therefore, valid concerns exist about the
potentially negative impact of biased guidelines on the
care and health outcomes of patients (DelgadoNoguera
et al., 2009; Shaneyfelt and Centor, 2009;
Tricoci et al., 2009; Alonso-Coello et al., 2010).
Guidelines of poor methodological quality may
lead clinicians to consider interventions that are
ineffective, costly, or harmful. Low-quality guidelines
may lead decision makers to invest in the
implementation of ill-informed recommendations.
Moreover, low-quality guidelines may reduce their
adoption by clinicians and policy makers. Known
barriers to the adoption of guidelines include lack
of clarity of recommendation development, ambiguous
recommendations, and inconsistent recommendations
across guidelines (Cote et al., 2009). Finally,
when combined with other barriers, such as lack of
time, limited understanding of how guidelines are
developed, and inadequate dissemination, it is easy
to understand why the uptake of some clinical
guidelines by clinicians has been disappointing
(Cote et al., 2009; Bishop et al., 2015; Slade et al.,
2015).
Many clinical practice guidelines on the management
of low back pain are available in the peerreviewed
literature. A systematic review of these
guidelines found that the quality of their methodology
was adequate but varied across guidelines (Dagenais
et al., 2010). However, the literature search for
this systematic review ended in 2009 (Dagenais
et al., 2010), and many guidelines have been published
or updated since (Cutforth et al., 2011; Livingston
et al., 2011; Philippine Academy of
Rehabilitation Medicine, 2011; Brosseau et al., 2012;
Delitto et al., 2012; Kung et al., 2012; North American
Spine Society, 2012; Scottish Intercollegiate
Guidelines Network, 2013; Kreiner et al., 2014). An
up-to-date systematic review of these guidelines is
needed to assess their methodological quality and
help guide appropriate management of low back
pain.
The purpose of this systematic review was to
review clinical practice guidelines, programmes of
care, and treatment protocols to identify effective
conservative (noninvasive) interventions for the
management of acute and chronic low back pain.
Methods
Review registration
The protocol for our systematic review was registered
on PROSPERO (CRD42015017762) and can be
accessed at www.crd.york.ac.uk/PROSPERO/display_
record.asp?ID=CRD42015017762.
Literature search
We developed the search strategy in consultation with
a health sciences librarian. A second librarian
reviewed the search strategy using the Peer Review of
Electronic Search Strategies Checklist (Sampson et al.,
2009). The search strategy combined terms relevant
to low back pain and guidelines and included free-text
words and subject headings specific to each database
(Supporting Information Appendix S1). The following
databases were searched from January 1, 2005, to
April 30, 2014: MEDLINE, EMBASE, CINAHL, PsycINFO,
Cochrane Database of Systematic Reviews,
Database of Abstracts of Reviews of Effects, Cochrane
Central Register of Controlled Trials, National Health
Services Economic Evaluation Database, Health Technology
Assessment Database and the Index to Chiropractic
Literature. Guidelines published prior to 2005
were considered outdated (Kung et al., 2012) and
were captured in a previous systematic review of
guidelines (Dagenais et al., 2010). We hand searched
reference lists of relevant guidelines for supplemental
documents relevant to the methodology of that guideline.
We searched the grey literature using the following:
National Guideline Clearinghouse (Agency for
Healthcare Research and Quality), Canadian Medical
Association Infobase, Guidelines International Network,
PEDro, Trip Database, American College of
Physicians Clinical Recommendations, Australian
Government, National Health and Medical Research
Council, Health Services/Technology Assessment
Texts, Institute for Clinical Systems Improvement,
National Institute for Health and Clinical Excellence
(NICE) Guidance, NICE Pathways, New Zealand
Guidelines Group, Scottish Intercollegiate Guidelines
Network (SIGN), and World Health Organization
guidelines approved by the Guidelines Review Committee.
Study selection
We used the following inclusion criteria:
(1) English language;
(2) targeting adults and/or children with low back pain with or without radiculopathy;
(3) J.J. Wong et al. Clinical practice guidelines for low back pain management guidelines, programmes of care, or treatment protocols;
(4) including recommendations for therapeutic noninvasive management.
We excluded guidelines that:
(1) did not include
treatment recommendations;
(2) were a summary or
copy of previous guidelines;
(3) were developed
solely on the basis of consensus opinion;
(4) did not
conduct a systematic literature search or critical
appraisal of studies used to derive recommendations;
and
(5) only targeted invasive (e.g. injection, surgery)
interventions.
Title and abstract screening
We used a two-stage (title/abstracts and full-text)
screening process with random pairs of independent
reviewers. Disagreements between pairs of reviewers
were resolved by discussion. A third reviewer
was used to resolve disagreements if consensus
could not be reached. We contacted authors if
additional information was necessary to determine
eligibility.
Critical appraisal of eligible guidelines
Randomly allocated pairs of independent reviewers
appraised relevant guidelines using the Appraisal of
Guidelines for Research and Evaluation II (AGREE
II) instrument (Table 1; Brouwers et al., 2010).
The AGREE II instrument is widely used to assess
the development and reporting of guidelines. It
consists of 23 items in six quality-related domains:
scope and purpose, stakeholder involvement, rigour
of development, clarity of presentation, applicability,
and editorial independence of guidelines
(Table 1). All reviewers were trained in critical
appraisal of guidelines using the AGREE II instrument.
Discussions were held between paired
reviewers to reach consensus on:
(1) individual
AGREE II items;
(2) overall guideline quality;
(3)
whether the guideline was high quality; and
(4)
whether modifications to the guideline would be
needed for use in specific jurisdictions (e.g. updating
literature, modifying the format of the guideline).
We contacted authors if additional
information was needed to complete the critical
appraisal.
Guidelines with poorly conducted systematic literature
searches (question 7 of AGREE II) or with
inadequate methods to critically appraise the evidence
(question 9 of AGREE II) were deemed to
have fatal flaws and were excluded from our synthesis.
These criteria are described as fundamental steps
to the development of evidence-based guidelines
(Ransohoff, 2013). Although not considered a fatal
flaw, we considered lack of editorial independence
from the funding body (question 22 of AGREE II) an
important limitation to the quality of the guideline.
The absence of editorial independence would
contribute to lower overall guideline quality, since
this may suggest poor reporting and lack of transparency
in guideline development (Alonso-Coello
et al., 2010).
Data extraction
One reviewer extracted data from high-quality
guidelines and built evidence tables. A second
reviewer checked the data that were extracted from
each guideline by comparing the extracted data with
the data reported in the guidelines. We did not
extract data on the use of interventional (invasive,
surgical) therapies.
Data synthesis
We synthesized recommendations from high-quality
guidelines using evidence tables. Recommendations
from high-quality guidelines were synthesized by
interventions and summarized according to whether
an intervention is
(1) recommended;
(2) not recommended
or
(3) lacked evidence to support or refute
its use.
We considered an intervention to be ‘recommended’
if the high-quality guideline used the following
terminology: ‘strongly recommended’,
‘recommended without any conditions required’,
‘should be used’, or ‘recommended for consideration’
[includes ‘offer’ or ‘consider’ (National Institute of
Health and Care Excellence, 2014)]. We stratified
recommendations by duration of low back pain (i.e.,
acute or chronic) and by the number of guidelines
recommending the intervention (‘recommended by
all guidelines’ or ‘recommended by most guidelines’,
i.e., more than 50% of guidelines).
Results
Figure 1
|
We screened 2504 titles and abstracts for eligibility
(Figure 1). Of those, 75 potentially relevant articles
were assessed in full-text screening and 61 were
ineligible. Primary reasons for ineligibility during
full-text screening were
(1) no systematic search or
critical appraisal methods (8/61);
(2) ineligible study
design (48/61);
(3) ineligible interventions (4/61);
and
(4) ineligible population (1/61).
We critically
appraised 13 eligible guidelines (reported in 14 articles/publications)
and needed to contact authors of
five guidelines (3/5 responded) to obtain additional
information to assess guideline quality (Airaksinen
et al., 2006; Nielens et al., 2006; Livingston et al.,
2011).
We identified 10 high-quality guidelines
Airaksinen et al., 2006;
Nielens et al., 2006;
van Tulder et al., 2006;
Chou et al., 2007;
National Institute of Health and Care Excellence, 2009;
Cutforth et al., 2011;
Livingston et al., 2011;
Delitto et al., J.J. Wong et al. Clinical practice guidelines for low back pain management
2012;
North American Spine Society, 2012;
Scottish
Intercollegiate Guidelines Network, 2013;
Kreiner
et al., 2014.
Inter-rater agreement for article screening
was k = 0.66 (95% confidence intervals 0.51;
0.81). Percentage agreement for guideline admissibility
during independent critical appraisal was 77%
(10/13). We reached consensus through discussion
for the three guidelines where there was disagreement
between reviewers’ independent appraisal
review (Livingston et al., 2011; Philippine Academy
of Rehabilitation Medicine, 2011; Brosseau et al.,
2012).
1. Methodological quality
The methodological quality of the 13 relevant guidelines
varied (Tables 2 and 3). Most guidelines did
not adequately address guideline applicability, particularly
facilitators and barriers, resource implication,
and/or monitoring or auditing criteria upon implementation
(8/13 guidelines; Airaksinen et al., 2006;
Nielens et al., 2006; Chou et al., 2007, 2009; Livingston
et al., 2011; Brosseau et al., 2012; Delitto
et al., 2012; Kreiner et al., 2014). Similarly, most
guidelines did not clearly indicate whether they
sought the views or preferences of the target population
(9/13 guidelines; Airaksinen et al., 2006; van
Tulder et al., 2006; Chou et al., 2007, 2009; Cutforth
et al., 2011; Livingston et al., 2011; Brosseau et al.,
2012; Delitto et al., 2012; Kreiner et al., 2014).
The 10 guidelines with high methodological quality
met the following criteria:
(1) systematic methods
to search for evidence (10/10);
(2) clearly described
strengths and limitations of the evidence (10/10);
(3)
considered health benefits, side-effects and risks (10/
10);
(4) provided an explicit link between recommendations
and supporting evidence (10/10);
(5)
clearly described methods for formulating recommendations
(9/10); and
(6) clearly described criteria
for selecting evidence (7/10; Tables 2).
However, the
high-quality guidelines had limitations, including
(1)
no description of an external review process (5/10)
(Airaksinen et al., 2006; Nielens et al., 2006; van
Tulder et al., 2006; Chou et al., 2007; Livingston
et al., 2011);
(2) no description of the procedure to
update the guideline (3/10) (Airaksinen et al., 2006;
Nielens et al., 2006; van Tulder et al., 2006); or
(3)
no declaration of competing interests by the guideline
development group (2/10) (Airaksinen et al.,
2006; Livingston et al., 2011).
Six guidelines were
published more than 5 years ago and need to be
updated (Airaksinen et al., 2006; Nielens et al.,
2006; van Tulder et al., 2006; Chou et al., 2007,
2009; National Institute of Health and Care Excellence,
2009).
The three low-quality guidelines had major limitations:
(1) no clear selection criteria of the literature
(2/3; Philippine Academy of Rehabilitation Medicine,
2011; Delitto et al., 2012);
(2) no clear description of
strengths and limitations of the literature (2/3; Brosseau
et al., 2012; Delitto et al., 2012);
(3) no clear
description of the methods used to formulate recommendations
(3/3; Philippine Academy of Rehabilitation
Medicine, 2011; Brosseau et al., 2012; Delitto
et al., 2012);
(4) no description of side-effects and
risks (2/3; Philippine Academy of Rehabilitation
Medicine, 2011; Brosseau et al., 2012);
(5) no
description of editorial independence from funders
(1/3; Delitto et al., 2012); and
(6) no declaration of
whether there were any competing interests by
guideline development group (3/3; Philippine Academy
of Rehabilitation Medicine, 2011; Brosseau
et al., 2012; Delitto et al., 2012).
2. High-quality guidelines
Nine of the 10 high-quality guidelines addressed
nonspecific low back pain (Table S1 and Tables 4). Of
these, one guideline targeted acute low back pain
(van Tulder et al., 2006), five targeted chronic low
back pain (Airaksinen et al., 2006; Nielens et al.,
2006; Chou et al., 2009; National Institute of Health
and Care Excellence, 2009; Scottish Intercollegiate
Guidelines Network, 2013), and three addressed
both acute and chronic (Chou et al., 2007; Cutforth
et al., 2011; Livingston et al., 2011). For chronic low
back pain, one guideline commented on multimodal
rehabilitation (combined physical and psychological
interventions) only (i.e., no recommendations for
any other noninvasive interventions; Chou et al.,
2009). The remaining guideline targeted lumbar disc
herniation with radiculopathy (Table S1 and Table 4;
Kreiner et al., 2014).
3. Acute nonspecific low back pain (four high-quality guidelines)
Interventions recommended by all guidelines:
(1) Advice, reassurance, or education with evidencebased
information on expected course of recovery
and effective self-care options for pain management
(van Tulder et al., 2006; Chou et al., 2007;
Cutforth et al., 2011; Livingston et al., 2011).
(2) Early return to activities, staying active, or
avoiding prescribed bed rest (van Tulder et al.,
2006; Chou et al., 2007; Cutforth et al., 2011;
Livingston et al., 2011).
(3) Paracetamol (acetaminophen) or nonsteroidal
anti-inflammatory drugs (NSAIDs) if indicated
(van Tulder et al., 2006; Chou et al., 2007; Cutforth
et al., 2011; Livingston et al., 2011), with
advice and consideration of risks and warning
symptoms and signs associated with these medications.
Only one guideline specified the recommended
type and dosage of NSAID use [i.e.
Ibuprofen, up to 800 mg three times per day
(maximum of 800 mg four times per day) or
diclofenac, up to 50 mg three times per day]
(Cutforth et al., 2011).
(4) Muscle relaxants (short course) alone or in addition
to NSAIDs if an initial trial of paracetamol
or NSAIDs failed to reduce pain on their own
(van Tulder et al., 2006; Chou et al., 2007; Cutforth
et al., 2011; Livingston et al., 2011), with
advice and consideration of sedation risks associated
with muscle relaxants (Chou et al., 2007;
Livingston et al., 2011). Only one guideline
specified the recommended type and dosage of
muscle relaxant use (i.e. Cyclobenzaprine, 10–
30 mg/day, with greatest benefit within 1 week,
although up to 2 weeks may be justified) (Cutforth
et al., 2011).
(5) Spinal manipulation for those not improving
with self-care options (Chou et al., 2007; Livingston
et al., 2011) or failing to return to normal
activities (van Tulder et al., 2006; Cutforth
et al., 2011).
Interventions recommended by most guidelines:
(1) Short-term use of opioids on rare occasions, to
control refractory, severe pain (3/4 guidelines)
(Chou et al., 2007; Cutforth et al., 2011; Livingston
et al., 2011). However, long-term use of
opioids may be associated with significant risks
related to the potential for tolerance, addiction
or abuse (Livingston et al., 2011). One guideline
did not address opioids for acute low back pain
(van Tulder et al., 2006).
4. Chronic nonspecific low back pain (eight high-quality guidelines)
Interventions recommended by all guidelines:
(1) Education including advice and information promoting
self-management (Cutforth et al., 2011);
evidence-based information on expected course
and effective self-care options (Chou et al., 2007;
Livingston et al., 2011); brief educational interventions
for short-term improvement (Airaksinen
et al., 2006); and advice to stay active or
make an early return to activities as tolerated
(Airaksinen et al., 2006; Nielens et al., 2006;
Chou et al., 2007; National Institute of Health
and Care Excellence, 2009; Cutforth et al., 2011;
Livingston et al., 2011; Scottish Intercollegiate
Guidelines Network, 2013).
(2) Exercises (Nielens et al., 2006; Chou et al., 2007;
Cutforth et al., 2011; Livingston et al., 2011;
Scottish Intercollegiate Guidelines Network,
2013) including supervised exercises (Airaksinen
et al., 2006; National Institute of Health and
Care Excellence, 2009) or yoga (Chou et al.,
2007; Cutforth et al., 2011; Livingston et al.,
2011). Three guidelines found insufficient evidence
to make recommendations for or against
any specific type of exercise (Airaksinen et al.,
2006; Nielens et al., 2006; Scottish Intercollegiate
Guidelines Network, 2013), but to instead
consider patient preferences (Airaksinen et al.,
2006). Recommended frequency/duration was a
maximum of eight sessions over up to 12 weeks
(National Institute of Health and Care Excellence,
2009).
(3) Manual therapy, including spinal manipulation
(Nielens et al., 2006; Chou et al., 2007; National
Institute of Health and Care Excellence, 2009;
Cutforth et al., 2011; Livingston et al., 2011) or
mobilizations (Airaksinen et al., 2006; Nielens
et al., 2006). Recommended treatment frequency/duration
was a maximum of nine sessions
over up to 12 weeks (National Institute of
Health and Care Excellence, 2009).
(4) Paracetamol or NSAIDs as therapeutic options
while considering side-effects and patient preferences
(Airaksinen et al., 2006; Nielens et al.,
2006; Chou et al., 2007; National Institute of
Health and Care Excellence, 2009; Cutforth
et al., 2011; Livingston et al., 2011; Scottish
Intercollegiate Guidelines Network, 2013).
(5) Short-term use of opioids when paracetamol or
NSAIDs provided insufficient pain relief (Airaksinen
et al., 2006; Nielens et al., 2006; Chou
et al., 2007; National Institute of Health and
Care Excellence, 2009; Cutforth et al., 2011; Livingston
et al., 2011; Scottish Intercollegiate
Guidelines Network, 2013). However, it is
important to take into account side-effects, risks,
and patient preference (Chou et al., 2007; Livingston
et al., 2009; Livingston et al., 2011; Nielens
et al., 2006) and to continue only with
regular re-assessments and when there is evidence
of ongoing pain relief (Scottish Intercollegiate
Guidelines Network, 2013).
(6) Multimodal rehabilitation that included physical
and psychological interventions (e.g., cognitive/
behavioural approaches and exercise) for
patients with high levels of disability or signifi-
cant distress (Airaksinen et al., 2006; Nielens
et al., 2006; Chou et al., 2007, 2009; National
Institute of Health and Care Excellence, 2009;
Cutforth et al., 2011; Livingston et al., 2011;
Scottish Intercollegiate Guidelines Network,
2013). Recommended treatment frequency/duration
was around 100 h over a maximum of up
to 8 weeks (National Institute of Health and
Care Excellence, 2009).
Interventions recommended by most guidelines:
(1) Massage (Chou et al., 2007; Cutforth et al.,
2011; Livingston et al., 2011; Nielens et al.,
2006; Scottish Intercollegiate Guidelines Network,
2013); however, one guideline recommended
against massage for chronic low back
pain (Airaksinen et al., 2006). This difference is
likely due to more recent evidence informing
the newer guidelines’ recommendations (Nielens
et al., 2006; Chou et al., 2007; National Institute
of Health and Care Excellence, 2009; Cutforth
et al., 2011; Livingston et al., 2011; Scottish
Intercollegiate Guidelines Network, 2013).
(2) Acupuncture (Nielens et al., 2006; Chou et al.,
2007; National Institute of Health and Care Excellence,
2009; Cutforth et al., 2011; Livingston
et al., 2011; Scottish Intercollegiate Guidelines
Network, 2013); however, one guideline recommended
against acupuncture (Airaksinen et al.,
2006). Again, this difference is likely due to more
recent evidence informing the newer guidelines’
recommendations (Chou et al., 2007; Cutforth
et al., 2011; Livingston et al., 2009; Livingston
et al., 2011; Nielens et al., 2006; Scottish Intercollegiate
Guidelines Network, 2013). Recommended
treatment frequency/duration was a
maximum of 10 sessions over up to 12 weeks
(National Institute of Health and Care Excellence,
2009).
(3) Antidepressants as an option for pain relief, but
possible side-effects (drowsiness, anticholinergic
effects) should be considered (Airaksinen et al.,
2006; Chou et al., 2007; National Institute of
Health and Care Excellence, 2009; Cutforth
et al., 2011; Livingston et al., 2011). However,
one guideline recommended that antidepressants
should not be used for chronic low back pain
(Scottish Intercollegiate Guidelines Network,
2013), while one guideline reported conflicting
evidence on the effectiveness of antidepressants
(Nielens et al., 2006).
Interventions not recommended by most guidelines:
(1) Muscle relaxants (Chou et al., 2007; Cutforth
et al., 2011; Livingston et al., 2011; Scottish
Intercollegiate Guidelines Network, 2013); six
guidelines made recommendations on the use of
muscle relaxants (Airaksinen et al., 2006; Nielens
et al., 2006; Chou et al., 2007; Cutforth
et al., 2011; Livingston et al., 2011; Scottish
Intercollegiate Guidelines Network, 2013). Of
those, four recommended against its use (Chou
et al., 2007; Cutforth et al., 2011; Livingston
et al., 2011; Scottish Intercollegiate Guidelines
Network, 2013) and two stated that muscle
relaxants can be considered as an option for pain
relief (Airaksinen et al., 2006; Nielens et al.,
2006). Specifically, one guideline reported that
the benefit of muscle relaxants could not be estimated
due to low-quality evidence (Chou et al.,
2007). Two guidelines reported that some muscle
relaxants (cyclobenzaprine, benzodiazepines)
may provide short-term pain relief, but cautioned
against long-term use due to side-effects
(drowsiness, dizziness, addiction, allergic sideeffects,
reversible reduction of liver function,
gastrointestinal effects) (Airaksinen et al., 2006;
Nielens et al., 2006). However, evidence on the
effectiveness of muscle relaxants was conflicting
(Nielens et al., 2006). One guideline did not
address muscle relaxants (National Institute of
Health and Care Excellence, 2009).
(2) Gabapentin (Airaksinen et al., 2006; Nielens
et al., 2006; Cutforth et al., 2011; Scottish Intercollegiate
Guidelines Network, 2013); one guideline
found insufficient evidence to recommend
for or against gabapentin for chronic low back
pain (Chou et al., 2007). Two guidelines did not
address gabapentin (National Institute of Health
and Care Excellence, 2009; Livingston et al.,
2011). Two guidelines recommended considering
gabapentin for neuropathic pain (but not chronic
low back pain) (Cutforth et al., 2011; Scottish
Intercollegiate Guidelines Network, 2013).
(3) Passive modalities (Airaksinen et al., 2006; Chou
et al., 2007; Cutforth et al., 2009; Cutforth et al.,
2011; Nielens et al., 2006), including transcutaneous
electrical nerve stimulation (TENS), laser,
interferential therapy or ultrasound (Airaksinen
et al., 2006; Chou et al., 2007; Cutforth et al.,
2009; Cutforth et al., 2011; Nielens et al., 2006).
Two guidelines found insufficient evidence for or
against laser (Chou et al., 2007; Cutforth et al.,
2011) or interferential therapy (Chou et al.,
2007). One guideline did not address passive
modalities (Livingston et al., 2011). One guideline
recommended that laser could be considered
a treatment option based on inconsistent evidence
(Scottish Intercollegiate Guidelines Network,
2013).
Lumbar disc herniation with radiculopathy (one high-quality guideline)
One high-quality guideline made recommendations
for the noninvasive management of lumbar disc herniation
with radiculopathy (Kreiner et al., 2014).
Five other high-quality guidelines (Airaksinen et al.,
2006; van Tulder et al., 2006; Chou et al., 2007,
2009; Livingston et al., 2011) included low back pain
with leg pain in their scope, but did not have specific
recommendations for the noninvasive management
of lumbar disc herniation with radiculopathy.
Recommended interventions:
(1) Spinal manipulation may be an option for symptomatic
relief (Kreiner et al., 2014).
(2) A limited course of structured exercise for
patients with mild to moderate symptoms. This
option was based on the consensus opinion of
the guideline development group (in the absence
of reliable evidence; Kreiner et al., 2014).
There was insufficient evidence to make a recommendation
for or against the use of traction, ultrasound,
and low-level laser therapy (Kreiner et al.,
2014).
Discussion
We conducted a systematic review of clinical practice
guidelines to identify effective conservative (noninvasive)
interventions for the management of acute
and chronic low back pain. Most recommended
interventions provide time-limited and small bene-
fits. Based on high-quality guidelines:
(1) patients
with low back pain should be provided with education
and encouraged to stay active and return-toactivity
as tolerated; and
(2) the management of
acute nonspecific low back pain includes spinal
manipulation (when not improving with self-care or
not returning to normal activities), paracetamol or
NSAIDs as indicated.
Based on high-quality guidelines,
the management of chronic nonspecific low
back pain includes the following:
(1)
paracetamol or
NSAIDs (although the effectiveness of paracetamol is
now being challenged by new evidence);
(2) shortterm
use of opioids for relief of refractory, severe
pain;
(3) exercises;
(4) manual therapy;
(5) acupuncture,
and
(6) multimodal rehabilitation (combined
physical and psychological treatment).
Finally, the
noninvasive management of lumbar disc herniation
with radiculopathy may include spinal manipulation
for symptomatic relief (Kreiner et al., 2014). Very
few guidelines provided information on recommended
dose and frequency of care.
Our results agree with recommended interventions
identified by a previous systematic review of guidelines
on low back pain (Dagenais et al., 2010). We
confirmed that most passive modalities (e.g. TENS,
laser, ultrasound) are not recommended for managing
chronic low back pain (Dagenais et al., 2010). In
addition, we found one recent high-quality guideline
on lumbar disc herniation with radiculopathy published
in 2012 (North American Spine Society,
2012).
However, the recommendation of paracetamol for
acute low back pain is challenged by a recent highquality
randomized controlled trial, which found that
paracetamol did not improve recovery time compared
with placebo for acute low back pain (Williams et al.,
2014). Previous systematic reviews found no evidence
supporting paracetamol for low back pain (Davies
et al., 2008; Machado et al., 2015). Moreover, some
high-quality guidelines used evidence from other conditions
(e.g., osteoarthritis) to inform recommended
interventions [paracetamol (Chou et al., 2007; Cutforth
et al., 2011; Livingston et al., 2011) or opioids
(Deyo et al., 2015)] for acute low back pain. Therefore,
it is possible that using evidence for the management
of other conditions, even if clinically relevant,
may lead to inadequate recommendations. Given the
risk of adverse events, we should reconsider the universal
endorsement of paracetamol for the management
of low back pain (Williams et al., 2014;
Machado et al., 2015). This emphasizes that guidelines
must be updated every 5 years to ensure that the
most up-to-date evidence is used to inform clinical
recommendations (Kung et al., 2012).
We found that high-quality guidelines lacked
details about the use of acupuncture for the management
of low back pain (Nielens et al., 2006; Chou
et al., 2007; National Institute of Health and Care
Excellence, 2009; Cutforth et al., 2011; Livingston
et al., 2011; Scottish Intercollegiate Guidelines Network,
2013). This is important because it is known
that different acupuncture techniques have different
levels of effectiveness (Furlan et al., 2005). Future
guidelines should consider stratifying evidence by
acupuncture technique and provide clear details
about the parameters for acupuncture use in patients
with low back pain.
Clinical practice guidelines of low methodological
quality are still being developed and published
(Philippine Academy of Rehabilitation Medicine,
2011; Brosseau et al., 2012; Delitto et al., 2012).
These guidelines typically fail to: (1) clearly outline
selection criteria of the literature; (2) adequately
describe strengths and limitations of the literature
and (3) adequately describe the methods used to
formulate recommendations (Ransohoff et al.,
2013). Our review highlights that the next generation
of high-quality guidelines must focus on applicability
to specific populations and clear
implementation strategies to promote adherence.
Nine of 13 eligible guidelines did not adequately
address the AGREE II applicability criteria. Recent
evidence suggests that favourable health and economic
outcomes could be achieved if evidenceinformed
decision making is used to manage low
back pain (Kosloff et al., 2013). However, current
clinical practice is ineffective in adhering to evidence-based
guideline recommendations (Kosloff
et al., 2013).
Future guidelines need to integrate the views and
preferences of the target population (patients, public)
into guideline development. Nine of 13 eligible
guidelines did not mention whether these views and
preferences were sought (Airaksinen et al., 2006; van
Tulder et al., 2006; Chou et al., 2007, 2009; Cutforth
et al., 2011; Livingston et al., 2011; Brosseau et al.,
2012; Delitto et al., 2012; Kreiner et al., 2014). Integrating
patient preferences into the guideline development
process: (1) improves uptake and real-world
efficiency of recommended healthcare interventions;
(2) enhances consumer empowerment, and (3)
informs individual patient preferences in clinical
decision making (Dirksen et al., 2013; Dirksen,
2014).
The recommendations included in clinical practice
guidelines typically involve the consensus of guideline
expert panels who are asked to consider decision
determinants, such as overall clinical benefit (effectiveness
and safety), value for money (cost-effectiveness),
consistency with expected societal and ethical
values, and feasibility of adoption into the health system
(Johnson et al., 2009). The scientific evidence
serves as the foundation from which recommendations
are built. Therefore, significant limitations are
associated with recommendations solely developed
using clinical opinions. Assembling, evaluation, and
summarizing of evidence are fundamental aspects of
guideline development, including a systematic review
and assessment of the quality of evidence (Ransohoff
et al., 2013). Recommendations based solely on opinion
may be liable to biases and conflicts of interest or
may not benefit patients (especially when patients’
views are not considered during guideline development).
Strengths and limitations
Our review had strengths. The literature search was
comprehensive, methodologically rigorous, and
checked by a second librarian. We outlined detailed
inclusion/exclusion criteria to identify relevant evidence-based
guidelines. Pairs of independent, trained
reviewers screened and critically appraised the literature.
This review used a recommended critical
appraisal instrument for evaluating guidelines to
maintain high methodological rigour (Brouwers
et al., 2010). Some guidelines lacked methodological
details, and we made multiple attempts to contact
authors so that our screening and critical appraisal
was as accurate as possible.
The main limitation was the restriction of guidelines
published in English. Most guidelines are published
in the language of the target users (e.g.,
Haute Autorite de Sante in France or El Instituto
Aragones de Ciencas de la Salud in Spain) (El Instituto
Aragones de Ciencas de la Salud, 2016; Haute
Autorite de Sante, 2016). It is possible that excluding
guidelines published in a language other than
English may have biased our results. However, it is
unclear whether recommendations that are not published
in English would differ from those published
in English. Finally, the external validity of our
results may be limited to users from English-speaking
jurisdictions. A second limitation concerns the
definitions used to classify acute and chronic low
back pain, which varied across guidelines. Four
guidelines defined chronic low back pain as pain
lasting more than 3 months (Airaksinen et al., 2006;
Nielens et al., 2006; van Tulder et al., 2006; Cutforth
et al., 2011). Three guidelines grouped recommendations
for subacute and chronic low back pain
into one category (Chou et al., 2007; National Institute
of Health and Care Excellence, 2009; Livingston
et al., 2011). Of those, two guidelines defined subacute/chronic
low back pain as pain lasting more
than 4 weeks (Chou et al., 2007; Livingston et al.,
2011), and one guideline defined persistent low
back pain as pain lasting more than 6 weeks
(National Institute of Health and Care Excellence,
2009). Finally, two guidelines did not provide a
clear definition of chronic low back pain (Chou
et al., 2009; Scottish Intercollegiate Guidelines Network,
2013). The different classifications used to
make recommendations for the management of low
back pain complicate the evidence synthesis and
may have led to the misclassification of recommendations.
Conclusions
Most high-quality guidelines target the noninvasive
management of nonspecific low back pain and recommend
education, staying active/exercise, manual
therapy, and paracetamol or NSAIDs as first-line
treatments. However, the endorsement of paracetamol
for acute low back pain is challenged by a
recent high-quality randomized controlled trial and
systematic review; therefore, guidelines need updating.
Some high-quality guidelines used evidence
from other conditions to inform recommendations,
which can lead to inadequate recommendations.
Most eligible guidelines poorly addressed the applicability
and implementation of recommendations.
Finally, guideline developers need to involve end
users during guideline development.
Acknowledgements
The authors acknowledge Carlo Ammendolia, J. David
Cassidy, Gail Lindsay, John Stapleton, Leslie Verville,
Michel Lacerte, Mike Paulden, Patrick Loisel, and Roger
Salhany for their invaluable contributions to this
review. The authors also thank Trish Johns-Wilson at
the University of Ontario Institute of Technology for
her review of the search strategy.
Author contributions
All authors have made substantial contributions to all of
the following: (1) the conception and design of the study,
or acquisition of data, or analysis and interpretation of
data; (2) drafting the article or revising it critically for
important intellectual content; and (3) final approval of
the version to be submitted.
References:
Airaksinen O, Brox JI, Cedraschi C, et al.
COST B13 Working Group on Guidelines for Chronic Low Back Pain Chapter 4.
European Guidelines for the Management of
Chronic Nonspecific Low Back Pain
European Spine Journal 2006 (Mar); 15 Suppl 2: S192–300
Alonso-Coello, P., Irfan, A., Sola, I., Gich, I., Delgado-Noguera, M., Rigau, D. (2010).
The quality of clinical practice guidelines over the last two decades:
A systematic review of guideline appraisal studies.
Qual Saf Health Care 19, e58.
Berrigan, L., Marshall, S., McCullagh, S., Velikonja, D., Bayley, M. (2011).
Quality of clinical practice guidelines for persons
who have sustained mild traumatic brain injury.
Brain Inj 25, 742–751.
Bishop, F.L., Dima, A.L., Ngui, J., Little, P., Moss-Morris, R., Foster, N.E. (2015).
“Lovely Pie in the Sky Plans”: A qualitative study of clinicians’ perspectives
on guidelines for managing low back pain in primary care in England.
Spine 40, 1842–1850.
Brosseau, L., Wells, G.A., Poitras, S., Tugwell, P., Casimiro, L., Novikov, M. (2012).
Ottawa panel evidence-based clinical practice guidelines
on therapeutic massage for low back pain.
J Bodyw Mov Ther 16, 424–455.
Brouwers, M.C., Kho, M.E., Browman, G.P., Burgers, J.S., Cluzeau, F. (2010).
AGREE II: Advancing guideline development, reporting
and evaluation in health care.
CMAJ 182, E839–E842.
Carey, T.S., Evans, A., Hadler, N., Kalsbeek, W., McLaughlin, C. (1995).
Care-seeking among individuals with chronic low back pain.
Spine 20, 312–317.
Carey, T.S., Evans, A.T., Hadler, N.M., Lieberman, G., Kalsbeek, W.D., Jackman, A.M. (1996).
Acute severe low back pain. A population-based study
of prevalence and care-seeking.
Spine 21, 339–344.
Cote P, Cassidy JD, Carroll L.
The Saskatchewan Health and Back Pain Survey. The Prevalence of
Neck Pain and Related Disability in Saskatchewan Adults
Spine (Phila Pa 1976). 1998 (Aug 1); 23 (15): 1689–1698
Cassidy, J.D., Cote, P., Carroll, L.J., Kristman, V. (2005).
Incidence and course of low back pain episodes in the general population.
Spine 30, 2817–2823.
Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr., Shekelle P, Owens DK:
Diagnosis and Treatment of Low Back Pain: A Joint Clinical
Practice Guideline from the American College of Physicians
and the American Pain Society
Annals of Internal Medicine 2007 (Oct 2); 147 (7): 478–491
Chou R, Loeser JD, Owens DK, Rosenquist RW, Atlas SJ, Baisden J, et al.
Interventional Therapies, Surgery, and Interdisciplinary Rehabilitation
for Low Back Pain: An Evidence-based Clinical Practice Guideline
From the American Pain Society
Spine (Phila Pa 1976). 2009 (May 1); 34 (10): 1066–1077
Cote P, Cassidy JD, Carroll L.
The Treatment of Neck and Low Back Pain:
Seeks Care? Who Goes Where?
Med Care. 2001 (Sep); 39 (9): 956–967
Cote, A.M., Durand, M.J., Tousignant, M., Poitras, S. (2009).
Physiotherapists and use of low back pain guidelines:
A qualitative study of the barriers and facilitators.
J Occup Rehabil 19, 94–105.
Cutforth, G., Peter, A., Taenzer, P. (2011).
The Alberta health technology assessment (HTA) ambassador program:
The development of a contextually relevant, multidisciplinary clinical
practice guideline for non-specific low back pain: A review.
Physiother Can 63, 278–286.
Cypress, B.K. (1983).
Characteristics of physician visits for back symptoms:
A national perspective.
Am J Public Health 73, 389–395.
Dagenais S, Tricco AC, Haldeman S.
Synthesis of Recommendations for the Assessment and Management
of Low Back Pain From Recent Clinical Practice Guidelines
Spine J. 2010 (Jun); 10 (6): 514–529
Davies, R.A., Maher, C.G., Hancock, M.J. (2008).
A systematic review of paracetamol for non-specific low back pain.
Eur Spine J 17, 1423–1430.
Delgado-Noguera, M., Tort, S., Bonfill, X., Gich, I., Alonso-Coello, P.
(2009).
Quality assessment of clinical practice guidelines for the prevention
and treatment of childhood overweight and obesity.
Eur J Pediatr 168, 789–799.
Delitto, A., George, S.Z., Van Dillen, L.R., Whitman, J.M., Sowa, G.,
Shekelle, P. (2012).
Low Back Pain: Clinical Practice Guidelines Linked to the International
Classification of Functioning, Disability, and Health from the Orthopaedic
Section of the American Physical Therapy Association
Journal of Orthopaedic & Sports Physical Therapy 2012; 42 (4): A1–A57
Deyo, R.A., Von Korff, M., Duhrkoop, D. (2015).
Opioids for low back pain.
BMJ 350, g6380.
Dirksen, C.D. (2014).
The use of research evidence on patient preferences in health care
decision-making: Issues, controversies and moving forward.
Expert Rev Pharmacoecon Outcomes Res 14, 785–794.
Dirksen, C.D., Utens, C.M., Joore, M.A., van Barneveld, T.A., Boer, B.,
Dreesens, D.H., van Laarhoven, H., Smit, C., Stiggelbout, A.M., van der Weijden, T. (2013).
Integrating evidence on patient preferences in healthcare
policy decisions: Protocol of the patient-VIP study.
Implement Sci 8, 64.
El Instituto Aragones de Ciencas de la Salud (2016).
El Instituto Aragones de Ciencas de la Salud Gu?as de Practica Cl?nica.
Furlan, A.D., van Tulder, M., Cherkin, D., Tsukayama, H., Lao, L. (2005).
Acupuncture and dry-needling for low back pain: An updated
systematic review within the framework of
the Cochrane collaboration.
Spine 30, 944–963.
Graham, I.D., Beardall, S., Carter, A.O., Glennie, J., Hebert, P.C. (2001).
What is the quality of drug therapy clinical
practice guidelines in Canada?
CMAJ 165, 157–163.
Haldeman S, Dagenais S.
A Supermarket Approach to the Evidence-informed
Management of Chronic Low Back Pain
Spine Journal 2008 (Jan); 8 (1): 1–7
Hasenfeld, R.S., Shekelle, P.G. (2003).
Is the methodological quality of guidelines declining in the US?
Comparison of the quality of US Agency for Health Care Policy
and Research (AHCPR) guidelines with those published subsequently.
Qual Saf Health Care 12, 428–434.
Haute Autorite de Sante (2016).
Haute Autorite de Sante Elaboration de recommandations de
bonne
pratique: Methode recommandations pour la pratique clinique.
Hincapie, C.A., Cassidy, J.D., Cote, P., Carroll, L.J., Guzman, J. (2010).
Whiplash injury is more than neck pain: A population-based
study of pain localization after traffic injury.
J Occup Environ Med 52, 434–440.
Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines (2011).
Clinical Practice Guidelines We Can Trust.
R. Graham, M. Mancher, D. Miller Wolman, S. Greenfield, and E. Steinberg, eds
(Washington, DC: National Academies Press (US)).
Johnson, A.P., Sikich, N.J., Evans, G., Evans, W., Giacomini, M., Glendining, M. (2009).
Health technology assessment: A comprehensive framework for
evidence-based recommendations in Ontario.
Int J Technol Assess Health Care 25, 141–150.
Knai, C., Brusamento, S., Legido-Quigley, H., Saliba, V., Panteli, D. (2012).
Systematic review of the methodological quality of clinical guideline
development for the management of chronic disease in Europe.
Health Policy 107, 157–167.
Kosloff TM, Elton D, Shulman SA, et al.
Conservative Spine Care: Opportunities to Improve the Quality
and Value of Care
Popul Health Manag. 2013 (Dec); 16 (6): 390–396
Kreiner, D.S., Hwang, S.W., Easa, J.E., Resnick, D.K., Baisden, J.L. (2014).
An evidence-based clinical guideline for the diagnosis and
treatment of lumbar disc herniation with radiculopathy.
Spine J 14, 180–191.
Kung, J., Miller, R.R., Mackowiak, P.A. (2012).
Failure of clinical practice guidelines to meet Institute of Medicine standards:
Two more decades of little, if any, progress.
Arch Intern Med 172, 1628–1633.
Livingston, C., King, V., Little, A., Pettinari, C., Thielke, A. (2011).
Evidence-Based Clinical Guidelines Project.
Evaluation and Management of Low Back Pain: PDF
A Clinical Practice Guideline Based on the Joint Practice Guideline
of the American College of Physicians and the
American Pain Society
(Salem, Oregon: Office for Oregon Health Policy and Research).
Machado, G.C., Maher, C.G., Ferreira, P.H., Pinheiro, M.B., Lin, C.W. (2015).
Efficacy and safety of paracetamol for spinal pain and osteoarthritis:
Systematic review and meta-analysis of randomised placebo controlled trials.
BMJ 350, h1225.
National Institute for Health and Clinical Excellence (NICE).
Low Back Pain: Early Management of Persistent Nonspecific Low Back Pain PDF
London: National Institute for Health and Care Excellence; 2009.
[Report No.: Clinical guideline 88].
National Institute of Health and Care Excellence (2014).
NICE Guidance.
Nielens, H., Van Zundert, J., Mairiaux, P., Gailly, J., Van Den Hecke, H. (2006).
Belgian Health Care Knowledge Centre.
Chronic Low Back Pain (KCE Report).
North American Spine Society (2012).
Evidence-Based Clinical Guidelines for Multidisciplinary Spine Care.
Diagnosis and Treatment of Lumbar Disc Herniation With Radiculopathy PDF
(Rockville MD: Agency for Healthcare Research and Quality).
Philippine Academy of Rehabilitation Medicine (2011).
Low back pain management guideline.
Ransohoff, D.F., Pignone, M., Sox, H.C. (2013).
How to decide whether a clinical practice guideline is trustworthy.
JAMA 309, 139–140.
Sampson, M., McGowan, J., Cogo, E., Grimshaw, J., Moher, D. (2009).
An evidence-based practice guideline for the peer review
of electronic search strategies.
J Clin Epidemiol 62, 944–952.
Scottish Intercollegiate Guidelines Network (2013).
Management of Chronic Pain. A National Clinical Guideline
(Rockville MD: Agency for Healthcare Research and Quality).
Shaneyfelt, T.M., Centor, R.M. (2009).
Reassessment of clinical practice guidelines: Go gently into that good night.
JAMA 301, 868–869.
Shaneyfelt, T.M., Mayo-Smith, M.F., Rothwangl, J. (1999).
Are guidelines following guidelines? The methodological quality of
clinical practice guidelines in the peer-reviewed medical literature.
JAMA 281, 1900–1905.
Shekelle, P.G., Woolf, S.H., Eccles, M., Grimshaw, J. (1999).
Clinical guidelines: Developing guidelines.
BMJ 318, 593–596.
Shekelle, P, Woolf, S, Grimshaw, JM, Schunemann, HJ, and Eccles, MP.
Developing Clinical Practice Guidelines: Reviewing, Reporting, and
Publishing Guidelines; Updating Guidelines; and the Emerging
Issues of Enhancing Guideline Implementability and
Accounting for Comorbid Conditions in Guideline Development
Implementation Science 2012 (Jul 4); 7: 62
Slade, S.C., Kent, P., Patel, S., Bucknall, T., Buchbinder, R. (2015).
Barriers to primary care clinician adherence to clinical guidelines
for the management of low back pain: a systematic review
and metasynthesis of qualitative studies.
Clin J Pain. 2015 Dec 24. [Epub ahead of print]
Tricoci, P., Allen, J.M., Kramer, J.M., Califf, R.M., Smith, S.C. Jr (2009).
Scientific evidence underlying the ACC/AHA clinical practice guidelines.
JAMA 301, 831–841.
van Tulder M, Becker A, Bekkering T, et al; On behalf of the COST B13 Working Group on Guidelines for the Management of Acute Low Back Pain in Primary Care.
Chapter 3. European Guidelines for the Management of Acute
Nonspecific Low Back Pain in Primary Care
European Spine Journal 2006 (Mar); 15 Suppl 2: S169–191
Walker, B.F. (2000).
The prevalence of low back pain: A systematic review of the literature from 1966 to 1998.
J Spinal Disord 13, 205–217.
Whitworth, J.A. (2006).
Best practices in use of research evidence to inform health decisions.
Health Res Policy and Syst 4, 11.
Williams, C.M., Maher, C.G., Latimer, J., McLachlan, A.J., Hancock,
M.J., Day, R.O., Lin, C.W. (2014).
Efficacy of paracetamol for acute low-back pain:
A double-blind, randomised controlled trial.
Lancet 384, 1586–1596.
Return to LOW BACK PAIN
Return to LOW BACK GUIDELINES
Since 11–25–2016
|